Redhill Biopharma Ltd. (RDHL) vs Sonoma Pharmaceuticals, Inc. (SNOA)
- Redhill Biopharma Ltd. RDHL 0.48 −4.00%
- Sonoma Pharmaceuticals, Inc. SNOA 1.13 −1.74%
Redhill Biopharma Ltd. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sonoma Pharmaceuticals, Inc. is the larger, with a market value of $5.5M against $4.4M — 1.2× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −10.3%) and the higher return on invested capital (0.00% vs −70.0%). Across the 16 metrics below, Redhill Biopharma Ltd. leads on 9 and Sonoma Pharmaceuticals, Inc. on 7.
Valuation
| Metric | RDHL | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | 0.00 | 0.20 | 2.11 |
| P/B | n/m | 0.66 | 1.78 |
| Price to free cash flow | n/m | n/m | 16.14 |
| EV/EBITDA | n/m | 0.70 | 12.58 |
| EV/Sales | 6.43 | (0.04) | 2.73 |
| Earnings yield | (127,222.23%) | (107.96%) | (4.38%) |
| Free cash flow yield | (246,986.61%) | (61.09%) | 0.00% |
Profitability
| Metric | RDHL | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 35.16% | 38.91% | 53.94% |
| Operating margin | 0.00% | (6.41%) | 0.00% |
| Net margin | 25.20% | (10.33%) | 0.00% |
| Free cash flow margin | 0.00% | (12.11%) | 0.00% |
| Return on equity | 0.00% | (42.52%) | (0.40%) |
| Return on assets | 0.00% | (13.85%) | (3.32%) |
| Return on invested capital | 0.00% | (69.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack